Domain | Measure |
---|---|
Reach | Number and percentage of patients excluded |
Reach | Number and percentage of patients served by eligible clinics |
Reach | Characteristics of participating patients versus general patient population |
Reach | Structured interview with Family Medicine director to qualitatively assess recruitment process |
Effectiveness | Number and percentage of patients completing urine drug screens |
Effectiveness | Overall rate of opioid prescribing by clinic and provider |
Effectiveness | Number and percentage of patients screened for mental health/substance use problems |
Effectiveness | Overall rate of opioid/benzodiazepine co-prescribing |
Effectiveness | Number and percentage of patients signing pain agreements |
Effectiveness | Number and percentage of opioid prescriptions above 120Â mg daily morphine equivalent |
Effectiveness | Number and percentage of providers who drop out of study at 3Â months |
Effectiveness | Structured interview with clinic lead to assess satisfaction, effectiveness, and subgroup differences |
Adoption (Setting) | Number and percentage of clinics excluded |
Adoption (Setting) | Number and percentage of clinics that participate |
Adoption (Setting) | Characteristics of participating clinics versus non-participants |
Adoption (Staff) | Number and percentage of staff excluded |
Adoption (Staff) | Number and percentage of staff who participate |
Adoption (Staff) | Characteristics of participating staff versus non-participants |
Implementation | Hours of consulting delivered/received per provider |
Implementation | Adaptations made to consulting protocol during intervention period |
Implementation | Cost of consulting intervention |
Implementation | Structured interview with clinic lead to assess consistency of consulting intervention |
Maintenance (Indiv.) | Number and percentage of patients completing urine drug screens (6-month follow-up) |
Maintenance (Indiv.) | Overall rate of opioid prescribing by clinic and provider (6-month follow-up) |
Maintenance (Indiv.) | Number and percentage of patients screened for mental health/substance use problems (6-month follow-up) |
Maintenance (Indiv.) | Overall rate of opioid/benzodiazepine co-prescribing (6-month follow-up) |
Maintenance (Indiv.) | Number and percentage of patients signing pain agreements (6-month follow-up) |
Maintenance (Indiv.) | Number and percentage of opioid prescriptions above 120Â mg daily morphine equivalent (6-month follow-up) |
Maintenance (Indiv.) | Number and percentage of providers who drop out of study (6-month follow-up) |
Maintenance (Indiv.) | Focus group with clinicians who made substantial changes |